Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Mps1/TTK inhibitor is an inhibitor of monopolar spindle 1 (Mps1/TTK; IC50 = 5.8 nM), a kinase involved in mitotic spindle checkpoint signaling that is overexpressed in certain cancerous tumors.1,2 It inhibits Mps1 phosphorylation of kinetochore scaffold 1 (KNL1) and increases the rate of mitosis and the number of cells entering anaphase within 15 minutes, indicating Mps1 checkpoint inhibition, when used at a concentration of 100 nM.1 Mps1/TTK inhibitor (50 and 100 nM) increases the number of missegregated chromosomes, with an increased number of errors at 100 nM compared with 50 nM. It also inhibits colony formation of DLD1, HCT116, and U2OS cells (IC50s = 24.6, 20.1, and 20.6 nM, respectively).
WARNING This product is not for human or veterinary use.
1. Molecular basis underlying resistance to Mps1/TTK inhibitors. Oncogene 35(19), 2518-2528 (2016).
2. MPS1 kinase as a potential therapeutic target in medulloblastoma. Oncol. Rep. 36(5), 2633-2640 (2016).